Protagonist

#药闻简讯# $Protagonist(PTGX)$ 与 Takeda 公司宣布，美国食品药品监督管理局（FDA）已接受 rusfertide 的新药申请（NDA），并给予优先审评。
Rusfertide 是一种用于治疗成人疾病的创新性、首例肝素模拟肽疗法。

Protagonist $Protagonist(PTGX)$ 的 rusfertide 目前正接受 FDA 审评，但这家生物技术公司已不再希望与合作伙伴武田（Takeda）共同推广这款潜在的真性红细胞增多症（PV）治疗药物。网页链接
根据双方在 202...

回复@Maggie小姐姐: 可以看看我关注过的一只股$Protagonist(PTGX)$ 上升的路上颠簸无数//@Maggie小姐姐:回复@纳斯达克是我提款机:应该没有，就是借机调整一下了。

回复@调御未来: 没事 几个月前传出jnj要收购protagonist 不也是不了了之 很正常//@调御未来:回复@调御未来:盲盒一半一半吧$Intellia(NTLA)$ $Cogent Biosciences(COGT)$ ，但最大的悬念还是没下来$Abivax(ABVX)$ 。
再拖怕就要黄了吧，前车之鉴CYTK的收购之后了无音讯了 查看图片

$Protagonist(PTGX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-001404  Act: 33  Size: 4 KB 网页链接

$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-26-005440  Size: 4 KB 网页链接

$Protagonist(PTGX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-003011  Act: 33  Size: 7 KB 网页链接

$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-26-034736  Size: 15 KB 网页链接

$Protagonist(PTGX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-26-002110  Act: 34  Size: 7 KB 网页链接

$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-26-001475  Size: 7 KB 网页链接

$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-26-001478  Size: 7 KB 网页链接

$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-26-001476  Size: 7 KB 网页链接

$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-26-001472  Size: 7 KB 网页链接

$Protagonist(PTGX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001104659-26-019696  Act: 34  Size: 12 MB 网页链接

$Protagonist(PTGX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-000988  Act: 33  Size: 4 KB 网页链接

$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-26-001479  Size: 7 KB 网页链接

$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-26-001474  Size: 7 KB 网页链接

$Protagonist(PTGX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-26-002724  Act: 34  Size: 13 MB 网页链接

$Protagonist(PTGX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-000710  Act: 33  Size: 9 KB 网页链接

$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-26-005443  Size: 5 KB 网页链接